Pilot Randomized Controlled Trial of Diabetes Group Prenatal Care.

Ebony B Carter, Kate Barbier, Pamela K Hill, Alison G Cahill, Graham A Colditz, George A Macones, Methodius G Tuuli, Sara E Mazzoni
Author Information
  1. Ebony B Carter: Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Washington University School of Medicine, St. Louis, Missouri.
  2. Kate Barbier: Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Washington University School of Medicine, St. Louis, Missouri.
  3. Pamela K Hill: Department of Obstetrics and Gynecology, Denver Health and Hospital, Denver, Colorado.
  4. Alison G Cahill: Department of Obstetrics and Gynecology, Dell Medical School, University of Texas at Austin, Austin, Texas.
  5. Graham A Colditz: Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine,, St. Louis, Missouri.
  6. George A Macones: Department of Obstetrics and Gynecology, Dell Medical School, University of Texas at Austin, Austin, Texas.
  7. Methodius G Tuuli: Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
  8. Sara E Mazzoni: Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.

Abstract

OBJECTIVE: This study aimed to determine the feasibility and effectiveness of diabetes Group Prenatal Care to increase patient engagement in diabetes self-care activities.
STUDY DESIGN: A pilot randomized controlled trial was conducted at two sites. Inclusion criteria were English or Spanish speaking, type 2 or gestational diabetes, 22 to 34 weeks of gestational age at first study visit, ability to attend group care at specified times, and willingness to be randomized. Exclusion criteria included type 1 diabetes, multiple gestation, major fetal anomaly, serious medical comorbidity, and serious psychiatric illness. Women were randomized to diabetes Group Prenatal Care or individual prenatal care. The primary outcome was completion of diabetes self-care activities, including diet, exercise, blood sugar testing, and medication adherence. Secondary outcomes included antenatal care characteristics, and maternal, neonatal, and diabetes management outcomes. Analysis followed the intention-to-treat principle.
RESULTS: Of 159 eligible Women, 84 (53%) consented to participate in the study and were randomized to group ( = 42) or individual ( = 42) prenatal care. Demographic characteristics were similar between study arms. Completion of diabetes self-care activities was similar overall, but Women in group care ate the recommended amount of fruits and vegetables on more days per week (5.1 days/week ± 2.0 standard deviation [SD] in group care vs. 3.4 days ± 2.6 SD in individual care;  < 0.01) and gained less weight per week during the study period (0.2 lbs/week [interquartile range: 0-0.7] vs. 0.5 lbs/week [interquartile range: 0.2-0.9];  = 0.03) than Women in individual care. Women with gestational diabetes randomized to group care were 3.5 times more likely to have postpartum glucose tolerance testing than those in individual care (70 vs. 21%; relative risk: 3.5; 95% confidence interval: 1.4-8.8). Other maternal, neonatal, and pregnancy outcomes were similar between study arms.
CONCLUSION: diabetes group care is feasible and shows promise for decreasing gestational weight gain, improving diet, and increasing postpartum diabetes testing among Women with pregnancies complicated by diabetes.
KEY POINTS: · Women with gestational diabetes in group care were 3.5 times more likely to return for postpartum glucose tolerance testing.. · Women with gestational diabetes in group care had less gestational weight gain during the study period.. · diabetes Group Prenatal Care is a promising intervention to improve outcomes for Women with diabetes in pregnancy..

References

  1. Am J Obstet Gynecol. 1982 Dec 1;144(7):768-73 [PMID: 7148898]
  2. Chronic Dis Can. 2011 Mar;31(2):58-64 [PMID: 21466755]
  3. J Womens Health (Larchmt). 2013 Dec;22(12):1056-61 [PMID: 24117000]
  4. Obstet Gynecol Clin North Am. 2007 Jun;34(2):173-99, vii [PMID: 17572266]
  5. Obstet Gynecol. 2009 Feb;113(2 Pt 1):451-61 [PMID: 19155920]
  6. Obstet Gynecol. 2013 Nov;122(5):1122-1131 [PMID: 24150027]
  7. Diabetologia. 2019 Jun;62(6):905-914 [PMID: 30843102]
  8. Pediatr Res. 2017 Nov;82(5):768-775 [PMID: 28604759]
  9. J Matern Fetal Neonatal Med. 2016 Sep;29(17):2852-6 [PMID: 26461437]
  10. Obstet Gynecol. 1996 Feb;87(2):163-8 [PMID: 8559516]
  11. Diabetes Care. 2000 Jul;23(7):943-50 [PMID: 10895844]
  12. J Matern Fetal Neonatal Med. 2017 May;30(10):1221-1226 [PMID: 27380055]
  13. Int J Endocrinol. 2012;2012:519267 [PMID: 22536233]
  14. Obstet Gynecol. 2018 Mar;131(3):e104-e108 [PMID: 29470344]
  15. Obstet Gynecol. 2018 Dec;132(6):e228-e248 [PMID: 30461693]
  16. Diabetes Care. 2003 Jan;26 Suppl 1:S5-20 [PMID: 12502614]
  17. J Midwifery Womens Health. 2006 Jul-Aug;51(4):266-272 [PMID: 16814221]
  18. Obstet Gynecol. 2003 Nov;102(5 Pt 1):1051-7 [PMID: 14672486]
  19. CMAJ. 2013 Sep 17;185(13):E635-44 [PMID: 23939218]
  20. Obstet Gynecol. 2018 Feb;131(2):e49-e64 [PMID: 29370047]
  21. Matern Child Health J. 2017 Feb;21(2):297-305 [PMID: 27423239]
  22. Matern Child Health J. 2015 Mar;19(3):635-42 [PMID: 24996952]

Grants

  1. P30 DK056341/NIDDK NIH HHS
  2. P30 DK092950/NIDDK NIH HHS
  3. T32 HD055172/NICHD NIH HHS

MeSH Term

Adult
Diabetes Mellitus, Type 2
Diabetes, Gestational
Female
Gestational Weight Gain
Glucose Tolerance Test
Group Processes
Humans
Pilot Projects
Pregnancy
Pregnancy in Diabetics
Prenatal Care
Self Care

Word Cloud

Created with Highcharts 10.0.0carediabetesgroupstudygestationalDiabetesrandomizedindividualwomen5GroupPrenatalCareWomentestingoutcomes03self-careactivitiestimes1similarvsweightpostpartum·criteriatype2includedseriousprenataldietcharacteristicsmaternalneonatal = 42armsperweeklessperiodlbs/week[interquartilerange:likelyglucosetolerancepregnancygainOBJECTIVE:aimeddeterminefeasibilityeffectivenessincreasepatientengagementSTUDYDESIGN:pilotcontrolledtrialconductedtwositesInclusionEnglishSpanishspeaking2234weeksagefirstvisitabilityattendspecifiedwillingnessExclusionmultiplegestationmajorfetalanomalymedicalcomorbiditypsychiatricillnessprimaryoutcomecompletionincludingexercisebloodsugarmedicationadherenceSecondaryantenatalmanagementAnalysisfollowedintention-to-treatprincipleRESULTS:159eligible8453%consentedparticipateDemographicCompletionoverallaterecommendedamountfruitsvegetablesdaysdays/week ± 2standarddeviation[SD]4days ± 26SD< 001gained0-07]2-09] = 0037021%relativerisk:95%confidenceinterval:4-88CONCLUSION:feasibleshowspromisedecreasingimprovingincreasingamongpregnanciescomplicatedKEYPOINTS:returnpromisinginterventionimprovePilotRandomizedControlledTrial

Similar Articles

Cited By (7)